Higher doses or irregular administration may increase the likelihood of nausea and upset stomach
2) Cellular Growth in Human Myotubes In human cell models 4 , IGF-1 directly drives hypertrophy markers (greater nuclei per myotube, higher fusion index, elevated contractile protein content), reinforcing its role in the cellular foundation of strength and size gains
Injectables are the most established option and are usually self-administered weekly in the belly, outer thighs, buttocks, or the back of the arms
GLP-1 medications are widely discussed in weight loss and diabetes conversations, but the language can sound technical and a bit off-putting at first
Coskun T, Urva S, Roell WC et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept